254 related articles for article (PubMed ID: 11840543)
41. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.
Saborio GP; Permanne B; Soto C
Nature; 2001 Jun; 411(6839):810-3. PubMed ID: 11459061
[TBL] [Abstract][Full Text] [Related]
42. Accumulation of mono-glycosylated form-rich, plaque-forming PrPSc in the second atypical bovine spongiform encephalopathy case in Japan.
Hagiwara K; Yamakawa Y; Sato Y; Nakamura Y; Tobiume M; Shinagawa M; Sata T
Jpn J Infect Dis; 2007 Sep; 60(5):305-8. PubMed ID: 17881874
[TBL] [Abstract][Full Text] [Related]
43. Variant Creutzfeldt-Jakob disease: immunocytochemical studies and image analysis.
Nailon WH; Ironside JW
Microsc Res Tech; 2000 Jul; 50(1):2-9. PubMed ID: 10871542
[TBL] [Abstract][Full Text] [Related]
44. Immunoreactivity enhancement with chelators for increasing the detection sensitivity of human PrPSc by Western blotting.
Kuczius T; Brinkmann B; Grassi J
Neurochem Int; 2007 Jan; 50(1):102-8. PubMed ID: 16962685
[TBL] [Abstract][Full Text] [Related]
45. Toluidine blue-O staining of prion protein deposits.
Sánchez A; Guzmán A; Ortiz A; Rembao D; Espinosa B; Zenteno E; Guevara J
Histochem Cell Biol; 2001 Dec; 116(6):519-24. PubMed ID: 11810193
[TBL] [Abstract][Full Text] [Related]
46. Prion-protein-specific aptamer reduces PrPSc formation.
Proske D; Gilch S; Wopfner F; Schätzl HM; Winnacker EL; Famulok M
Chembiochem; 2002 Aug; 3(8):717-25. PubMed ID: 12203970
[TBL] [Abstract][Full Text] [Related]
47. Creutzfeldt-Jakob disease and inclusion body myositis: abundant disease-associated prion protein in muscle.
Kovacs GG; Lindeck-Pozza E; Chimelli L; Araújo AQ; Gabbai AA; Ströbel T; Glatzel M; Aguzzi A; Budka H
Ann Neurol; 2004 Jan; 55(1):121-5. PubMed ID: 14705121
[TBL] [Abstract][Full Text] [Related]
48. Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease.
Zou WQ; Capellari S; Parchi P; Sy MS; Gambetti P; Chen SG
J Biol Chem; 2003 Oct; 278(42):40429-36. PubMed ID: 12917418
[TBL] [Abstract][Full Text] [Related]
49. Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues.
Jiménez-Huete A; Lievens PM; Vidal R; Piccardo P; Ghetti B; Tagliavini F; Frangione B; Prelli F
Am J Pathol; 1998 Nov; 153(5):1561-72. PubMed ID: 9811348
[TBL] [Abstract][Full Text] [Related]
50. Prion disease with a 144 base pair insertion: unusual cerebellar prion protein immunoreactivity.
Gelpi E; Kovacs GG; Ströbel T; Koperek O; Voigtländer T; Liberski PP; Budka H
Acta Neuropathol; 2005 Nov; 110(5):513-9. PubMed ID: 16155763
[TBL] [Abstract][Full Text] [Related]
51. Oligomeric forms of peptide fragment PrP(214-226) in solution are preferentially recognized by PrP(Sc)-specific antibody.
Ulrih NP; Skrt M; Veranic P; Galvani V; Vranac T; Curin Serbec V
Biochem Biophys Res Commun; 2006 Jun; 344(4):1320-6. PubMed ID: 16650818
[TBL] [Abstract][Full Text] [Related]
52. Association between deposition of beta-amyloid and pathological prion protein in sporadic Creutzfeldt-Jakob disease.
Debatin L; Streffer J; Geissen M; Matschke J; Aguzzi A; Glatzel M
Neurodegener Dis; 2008; 5(6):347-54. PubMed ID: 18349519
[TBL] [Abstract][Full Text] [Related]
53. Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts.
Laffont-Proust I; Hässig R; Haïk S; Simon S; Grassi J; Fonta C; Faucheux BA; Moya KL
Biol Chem; 2006 Mar; 387(3):297-300. PubMed ID: 16542151
[TBL] [Abstract][Full Text] [Related]
54. Epitope mapping of a PrP(Sc)-specific monoclonal antibody: identification of a novel C-terminally truncated prion fragment.
Kosmač M; Koren S; Giachin G; Stoilova T; Gennaro R; Legname G; Serbec VČ
Mol Immunol; 2011 Feb; 48(5):746-50. PubMed ID: 21176851
[TBL] [Abstract][Full Text] [Related]
55. Protease-sensitive conformers in broad spectrum of distinct PrPSc structures in sporadic Creutzfeldt-Jakob disease are indicator of progression rate.
Kim C; Haldiman T; Cohen Y; Chen W; Blevins J; Sy MS; Cohen M; Safar JG
PLoS Pathog; 2011 Sep; 7(9):e1002242. PubMed ID: 21931554
[TBL] [Abstract][Full Text] [Related]
56. Beyond PrP9res) type 1/type 2 dichotomy in Creutzfeldt-Jakob disease.
Uro-Coste E; Cassard H; Simon S; Lugan S; Bilheude JM; Perret-Liaudet A; Ironside JW; Haik S; Basset-Leobon C; Lacroux C; Peoch' K; Streichenberger N; Langeveld J; Head MW; Grassi J; Hauw JJ; Schelcher F; Delisle MB; Andréoletti O
PLoS Pathog; 2008 Mar; 4(3):e1000029. PubMed ID: 18389084
[TBL] [Abstract][Full Text] [Related]
57. Creutzfeldt-Jakob disease (CJD) with a mutation at codon 148 of prion protein gene: relationship with sporadic CJD.
Pastore M; Chin SS; Bell KL; Dong Z; Yang Q; Yang L; Yuan J; Chen SG; Gambetti P; Zou WQ
Am J Pathol; 2005 Dec; 167(6):1729-38. PubMed ID: 16314483
[TBL] [Abstract][Full Text] [Related]
58. Biochemical Characterization of Prions.
Fiorini M; Bongianni M; Monaco S; Zanusso G
Prog Mol Biol Transl Sci; 2017; 150():389-407. PubMed ID: 28838671
[TBL] [Abstract][Full Text] [Related]
59. Eight prion strains have PrP(Sc) molecules with different conformations.
Safar J; Wille H; Itri V; Groth D; Serban H; Torchia M; Cohen FE; Prusiner SB
Nat Med; 1998 Oct; 4(10):1157-65. PubMed ID: 9771749
[TBL] [Abstract][Full Text] [Related]
60. Prion diseases and emerging prion diseases.
Yokoyama T; Mohri S
Curr Med Chem; 2008; 15(9):912-6. PubMed ID: 18473798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
